GlassScriptPhysician profile
Michelle M Lewis
NPI 1871672931
$1,915.48
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $366 · 2021: $576 · 2022: $473 · 2023: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $224.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $519.48 | 2019-2023 | |
| Therapeuticsmd, INC. | $371.62 | 2019-2022 | |
| Pfizer INC. | $158.97 | 2020-2023 | |
| Allergan, INC. | $77.82 | 2019-2020 | |
| Ascend Therapeutics US, LLC | $76.36 | 2019-2020 | |
| Avion Pharmaceuticals | $72.48 | 2021-2023 | Balcoltra |
| Evofem Biosciences, INC. | $66.37 | 2022 | |
| Exeltis, USA INC. | $62.61 | 2020 | |
| Mayne Pharma Commercial LLC | $62.22 | 2022-2023 | |
| Biohaven Pharmaceuticals, INC. | $55.26 | 2021 | |
| Nalpropion Pharmaceuticals LLC | $54.51 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $50.48 | 2020-2021 | |
| Amag Pharmaceuticals, INC. | $49.99 | 2019-2020 | |
| Agile Therapeutics, INC. | $39.92 | 2021-2022 | |
| Organon LLC | $39.74 | 2021-2023 | Nexplanon |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $32.92 | 2019-2020 | |
| Astellas Pharma US INC | $32.84 | 2023 | Veozah |
| Scynexis, INC. | $21.88 | 2022 | |
| Genentech USA, INC. | $15.96 | 2021 | |
| Coopersurgical, INC. | $14.70 | 2019 | |
| Daiichi Sankyo INC. | $14.10 | 2019 | |
| Currax Pharmaceuticals LLC | $12.99 | 2022 | |
| Lupin INC. | $12.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.